Discontinued — last reported Q3 '23
An increase suggests potential overvaluation of assets or deteriorating business prospects in the region, while a decrease indicates stable asset valuation and successful long-term investment management.
This metric represents non-cash charges recognized when the carrying value of long-lived assets, such as intangible asse...
Peers in the pharmaceutical industry frequently report similar impairment charges related to failed clinical trials or the loss of patent exclusivity for key products within specific markets.
lly_segment_pr_asset_impairment_charges